| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7623 |
| Human Intestinal Absorption | HIA+ | 0.9962 |
| Caco-2 Permeability | Caco2+ | 0.8866 |
| P-glycoprotein Substrate | Non-substrate | 0.6663 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9298 |
| Non-inhibitor | 0.9513 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8624 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9320 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7745 |
| CYP450 2D6 Substrate | Non-substrate | 0.9123 |
| CYP450 3A4 Substrate | Non-substrate | 0.7058 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5392 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9528 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9700 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9016 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9721 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8670 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9456 |
| Non-inhibitor | 0.9622 |
| AMES Toxicity | Non AMES toxic | 0.9434 |
| Carcinogens | Non-carcinogens | 0.7315 |
| Fish Toxicity | High FHMT | 0.7529 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9568 |
| Honey Bee Toxicity | High HBT | 0.8224 |
| Biodegradation | Ready biodegradable | 0.9063 |
| Acute Oral Toxicity | III | 0.8777 |
| Carcinogenicity (Three-class) | Non-required | 0.6027 |